Pharmabiz2d
Valneva submits label extension application for Ixchiq with UK MHRA to expand its use to adolescents aged 12 to 17 years in EU
Saint Herblain, France Tuesday, April 1, 2025, 16:00 Hrs [IST] ...
Valneva’s Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and Above
With this extension, IXCHIQ ® , the first vaccine against the chikungunya virus (CHIKV), is now available for administration for individuals 12 ...
Valneva granted EC marketing authorization for Ixchiq vaccine
Valneva (VALN) announced that the European Commission has granted marketing authorization in Europe for Valneva’s single-dose vaccine, Ixchiq, ...
Yahoo Finance2d
Valneva’s Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and Above
With this extension, IXCHIQ ®, the first vaccine against the chikungunya virus (CHIKV), is now available for administration for individuals 12 years of age and older in the European Union (EU).
Yahoo Finance4d
Valneva Submits Adolescent Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to UK MHRA
This submission follows the recent positive opinion of the European Medicines Agency (EMA) on extension of IXCHIQ ® label to adolescents in the European Union (EU) 2. IXCHIQ ® is the world’s ...
Yahoo Finance4d
Valneva Submits Adolescent Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to UK MHRA
This submission follows the recent positive opinion of the European Medicines Agency (EMA) on extension of IXCHIQ ® label to adolescents in the European Union (EU) 2. IXCHIQ ® is the world’s first ...